In this podcast episode of Disruptive Technology, we talk about everything you always wanted to know but were afraid to ask about one of the greatest advances in medical science — gene editing using CRISPR technology.

We’ll tell you what the CRISPR gene editing technology is. How it works. And what it is capable of doing — both good and bad. This technology holds the promise of changing how diseases are treated, especially those caused by genetic mutations. Gene editing is currently coming up with cures for diseases that are untreatable today.

Tony & Paul take a deep dive into the top questions people are asking.

How will this change the world in the future and how it will change industries and sectors in the US economy.

What could go wrong?

How could this technology be misused?

Who will effectively enforce any ethical regulations?

What groups will actively oppose this technology, who will benefit, and who will be hurt?

How does the US regulate CRISPR and gene editing research now and how strict are the medical ethics regulations?

Tony & Paul talk extensively about gene editing using CRISPR technology and its potential to change the world.

It’s an episode that covers a great deal of ground – solid information for any Investor who is looking to gather insight on the changes in the landscape and use that knowledge to take their business to the next level.

Listen to additional episodes in this series

 

RECENT EPISODES